Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Sonoma Pharmaceuticals, Inc. (SNOA : NSDQ)

• Company Description    Sonoma Pharmaceuticals operates as a pharmaceutical company. It develops and markets solutions for the treatment of dermatological conditions, animal health and advanced tissue care. The company operates primarily in United States, Latin America and Europe. Sonoma Pharmaceuticals formerly known as Oculus Innovative Sciences and is headquatered in Petaluma, California. Number of Employees: 8

• Price / Volume Information    Yesterday's Closing Price: $1.10 Daily Weekly Monthly 20 Day Moving Average: 423,000 shares Shares Outstanding: 4.79 (millions) Market Capitalization: $5.26 (millions) Beta: 1.28 52 Week High: $6.92 52 Week Low: $0.85 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -38.89% -41.87% 12 Week -62.46% -65.29% Year To Date -69.78% -73.23%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 5445 CONESTOGA COURT SUITE 150 - BOULDER,CO 80301 USA ph: 800-759-9305 fax: 707-283-0551 ir@sonomapharma.com http://www.sonomapharma.com

• General Corporate Information    Officers Amy Trombly - President; Chief Executive Officer Jerome Dvonch - Chief Financial Officer Jay Edward Birnbaum - Director Philippe Weigerstorfer - Director Jerry McLaughlin - Director Peer Information Sonoma Pharmaceuticals, Inc. (GSAC) Sonoma Pharmaceuticals, Inc. (CASIF) Sonoma Pharmaceuticals, Inc. (ALCD.) Sonoma Pharmaceuticals, Inc. (OMNN) Sonoma Pharmaceuticals, Inc. (CGPI.) Sonoma Pharmaceuticals, Inc. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 83558L303 SIC: 3841 Fiscal Year Fiscal Year End: March Last Reported Quarter: 12/01/25 Next Expected EPS Date: 06/16/26 Share - Related Items Shares Outstanding: 4.79 Most Recent Split Date: 8.00 (0.05:1) Beta: 1.28 Market Capitalization: $5.26 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 06/16/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.55 Price/Cash Flow: - Price / Sales: 0.30 EPS Growth vs. Year Ago Period: 40.68% vs. Previous Quarter: -169.23% Sales Growth vs. Year Ago Period: 22.03% vs. Previous Quarter: -22.39% ROE 03/31/26 - - 12/31/25 - -42.56 09/30/25 - -45.46 ROA 03/31/26 - - 12/31/25 - -11.97 09/30/25 - -13.95 Current Ratio 03/31/26 - - 12/31/25 - 2.88 09/30/25 - 2.89 Quick Ratio 03/31/26 - - 12/31/25 - 2.00 09/30/25 - 2.05 Operating Margin 03/31/26 - - 12/31/25 - -9.42 09/30/25 - -11.49 Net Margin 03/31/26 - - 12/31/25 - -19.04 09/30/25 - -20.57 Pre-Tax Margin 03/31/26 - - 12/31/25 - -19.47 09/30/25 - -20.20 Book Value 03/31/26 - - 12/31/25 - 2.02 09/30/25 - 2.30 Inventory Turnover 03/31/26 - - 12/31/25 - 3.12 09/30/25 - 3.13 Debt-to-Equity 03/31/26 - - 12/31/25 - 0.00 09/30/25 - 0.00 Debt-to-Capital 03/31/26 - - 12/31/25 - 0.00 09/30/25 - 0.00

Powered by Zacks Investment Research ©